Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Free-flap volume correlates with body mass index in patients with tongue squamous cell carcinoma.
Saito M, Nakane A, Asaumi R, Kagifuku Y, Ishii M, Hasegawa S, Yoshimi K, Yamaguchi K, Nakagawa K, Hirai H, Kuroshima T, Tomioka H, Tohara H. Saito M, et al. Among authors: tomioka h. Laryngoscope Investig Otolaryngol. 2023 Aug 16;8(5):1210-1216. doi: 10.1002/lio2.1131. eCollection 2023 Oct. Laryngoscope Investig Otolaryngol. 2023. PMID: 37899853 Free PMC article.
Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP. Miyamoto A, et al. Sci Rep. 2024 May 3;14(1):10162. doi: 10.1038/s41598-024-60833-w. Sci Rep. 2024. PMID: 38702426 Free PMC article.
Neutrophil-Lymphocyte Ratio in Patients With Acute Schizophrenia.
Sugita S, Tomioka H, Mera K, Tazaki T, Nishiyama H, Yamada H, Sanada K, Inamoto A, Iwanami A. Sugita S, et al. Among authors: tomioka h. Cureus. 2024 Jan 12;16(1):e52181. doi: 10.7759/cureus.52181. eCollection 2024 Jan. Cureus. 2024. PMID: 38222994 Free PMC article.
A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19.
Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Takihara T, Sekiya K, Tomii K, Tomioka H, Kita H, Nishizaka Y, Fukui M, Miyata T, Harigae H. Hirai T, et al. Among authors: tomioka h. Sci Rep. 2024 Jan 2;14(1):165. doi: 10.1038/s41598-023-50445-1. Sci Rep. 2024. PMID: 38168544 Free PMC article. Clinical Trial.
793 results